Drug-Resistant Bacteria in ICUs Lead to Over 90% Mortality Rate
Drug-resistant bacteria are spreading at an alarming rate among patients in intensive care units (ICUs) across Bangladesh's hospitals, leading to a mortality rate exceeding 90% for infected individuals. Two recent studies conducted by the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDRR,B) revealed these critical findings. The first study analyzed data from 373 severely ill adult patients admitted to the ICU of a specialized government hospital in Dhaka between July 2023 and February 2024. It found that 53% of patients who did not have these bacteria upon admission became infected during their treatment. A second study focused on 363 newborns admitted to the neonatal ICU (NICU) of the same hospital from December 2023 to September 2024. The research results have been published in the international medical journals 'Microbiology Spectrum' and 'Antimicrobial Resistance and Infection Control'.
Four main Gram-negative bacteria—E. coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa—have been identified as the primary culprits for spreading hospital-acquired infections. These bacteria are prone to developing antibiotic resistance and can cause severe infections. Researchers attribute the spread to limitations in hospital infection control systems, shortages of medical equipment, and overcrowding, which contribute to new infections among critically ill patients. The studies indicated that 48.5% of ICU patients showed the presence of these drug-resistant bacteria in their intestines, a condition known as colonization, which poses a risk of transmission to others even if the patient is not symptomatic. Notably, out of 198 patients admitted without these bacteria, 105 became colonized or infected during their ICU stay, highlighting the internal spread within hospitals. Whole-genome sequencing technology was employed to demonstrate how these silently present bacteria can evolve into life-threatening infections.
Gazi Md. Salahuddin Mamun, lead author and assistant scientist at ICDDRR,B, stated that regular patient monitoring, laboratory tests, and genome sequencing in ICUs can identify the spread of resistant bacteria and how dormant microbes can develop into severe infections. Fahmida Chowdhury, head of ICDDRR,B's Antimicrobial Resistance (AMR) Research Unit and chief investigator, emphasized that hospitals should be places of healing, not sources of new infections. She stressed the urgent need to strengthen infection prevention measures, hospital hygiene, and responsible antibiotic use to protect critically ill patients.
The research highlights a critical challenge in healthcare systems: the rise of antimicrobial resistance (AMR) within hospital settings, particularly in ICUs. This phenomenon poses a significant threat to patient outcomes, as common infections become untreatable. The findings suggest systemic issues within hospital infection control protocols, resource allocation, and patient management are contributing factors. Addressing this requires a multi-pronged approach focusing on enhanced surveillance, stricter adherence to hygiene standards, and judicious antibiotic stewardship. The long-term implications for public health necessitate a proactive strategy to combat AMR, considering the increasing reliance on antibiotics and the potential for widespread untreatable infections in the coming decade.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.